secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0001823239-24-000082
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Maravai shareholders elect directors, ratify auditor, approve executive compensation at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected four director nominees: Benjamin Daverman, Susannah Gray, Carl Hull, Constantine Mihas to three-year terms.
- Ratified Ernst & Young LLP as independent auditor for FY 2024 with 236,288,478 votes for, 268,742 against.
- Non-binding advisory approval of named executive officer compensation with 223,303,654 votes for.
- Quorum met with 236,931,940 shares represented out of 251,748,827 outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323924000082/0001823239-24-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323924000082/mrvi-20240523.htm
  HTML page:      https://secwatch.observer/filing/0001823239-24-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer